Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nilotinib in Dementia With Lewy Bodies (DLB)
NCT04002674Phase 2Completed
- Sponsor
- Georgetown University
- Start
- Jul 2019
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nilotinib in dementia with Lewy bodies (DLB), sponsored by Georgetown University. Started Jul 2019; status: completed.
02
Drugs
nilotinib
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on NCT04002674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04002674.